|
|
|
Volumn 4, Issue 6, 1995, Pages 319-336
|
|
Transcription factors as drug targets: opportunities for therapeutic selectivity.
a
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ADRENERGIC RECEPTOR;
HIGH DENSITY LIPOPROTEIN;
TRANSCRIPTION FACTOR;
BLOOD;
CARDIOVASCULAR DISEASE;
DRUG DESIGN;
DRUG EFFECT;
EUKARYOTIC CELL;
GENETIC TRANSCRIPTION;
HUMAN;
IMMUNITY;
OSTEOPOROSIS;
REVIEW;
CARDIOVASCULAR DISEASES;
DRUG DESIGN;
EUKARYOTIC CELLS;
HUMANS;
IMMUNITY;
LIPOPROTEINS, HDL;
OSTEOPOROSIS;
RECEPTORS, ADRENERGIC;
TRANSCRIPTION FACTORS;
TRANSCRIPTION, GENETIC;
|
|
EID: 0029186340
PISSN: 10522166
EISSN: None
Source Type: Journal
DOI: None Document Type: Review |
|
Times cited : (24)
|
|
References (137)
|
